TOP TIERMARKET NEWSWIRE
News & sentiment

INNOVENT BIOLOGICS I (IVBXF) — News & AI sentiment

INNOVENT BIOLOGICS I (IVBXF) news roundup. 1 story in the past week, 3 over 30 days. Average 30-day sentiment is 65.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 63/100
30d stories
3
avg sentiment 65.3/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

IVBXF news in the last 24 hours, 7 days, 30 days and 90 days

How much IVBXF coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowIVBXF storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days163/100IVBXF headlines →
Last 30 days365.3/100IVBXF headlines →
Last 90 days1860.4/100IVBXF headlines →

Latest stories on IVBXF

2d ago
Oct 9
Sep 29
Sep 28
Sep 28
Sep 28
Sep 28
Sep 23
Health Care Roundup: Market Talk
Yahoo Top50 · neutralgeneral
Sep 15
Sep 15
Health Care Roundup: Market Talk
WSJ Markets50 · neutralgeneral
Sep 14
Sep 2
Roche, Simcere Pharma Strike Drug Licensing Deal
Morningstar63 · neutralproduct/pr
Sep 2
Health Care Roundup: Market Talk
WSJ Markets50 · neutralgeneral
Aug 27
Aug 26
Aug 25
Aug 10
Aug 10
Jul 14
Jul 14
Jul 3
Jun 30
Jun 25
Jun 2
May 30
Open IVBXF in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →